ArticleBlood advances2023

TP53 mutations predict for poor outcomes in patients with newly diagnosed aggressive B-cell lymphomas in the current era.

Daniel J Landsburg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.